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Depression is among the common mental illnesses in the United States affecting 1 in 10 
Americans. The U.S. Preventive Services Task Force recommended screening for 
depression irrespective of the risk factors. Yet, providers struggle to implement 
depression screening. Inadequate use of Patient Health Questionnaire-9 (PHQ-9) 
screening tool to identify and manage depression can lead to poor patient outcomes. 
PHQ-9 is valid and reliable tool used to diagnose depression and monitor treatment 
response. The purpose of this project was to develop, deliver, and evaluate an educational 
program for providers on the use of the PHQ-9 screening tool for the identification of 
depression. The design and implementation of this educational module was guided by the 
Iowa model of evidence-based practice. The research question focused on educating 
providers managing depression in an outpatient psychiatric clinic about using the PHQ-9 
tool and assessing their knowledge and confidence levels before education, immediately 
after education intervention, and 1 month after. Six providers participated in the 
educational program and completed the pretest and posttest to evaluate the education. 
The results confirmed a significant change in the mean scores for participants’ knowledge 
and confidence levels postintervention.. Enhancing provider’s knowledge and confidence 
levels can facilitate proper diagnosis and treatment for depression, promote the health of 
clients’ families, and prevent health-related complications associated with depression, 
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Section 1: Introduction 
Introduction 
Depression is among the common mental illnesses in the United States. It affects 
one in 10 Americans at some stage of their lives (National Institute of Mental Health 
[NIMH], 2018). According to the National Survey on Drug Use and Health, more than 16 
million adults in the United States (6.7%) have experienced at least one major depressive 
episode, and that number includes only cases of depression that are known (Ahrnsbrak, 
Bose, Hedden, Lipari, & Park-Lee, 2016). Researchers suggest that depression may be 
even more common; in fact, only an estimated one out of every five individuals who 
experience a major depressive disorder ever receives clinical help for depression 
(Ahrnsbrak et al., 2016; Morin, 2018).  
According to NIMH (2015), the number of patients diagnosed with depression 
increases by about 20% each year. If depression is left untreated, it can cause disabling 
symptoms that can negatively affect the quality of life. About two-thirds of suicides occur 
because of depression (Ledford, 2014). According to the depression report from National 
Alliance on Mental Illness (2019), women are 70% more likely to have depression 
compared to men, and young adults are 60% more likely to experience depression than 
adults 50 years and older. Practitioners diagnose depression when symptoms of sadness, 
loneliness, irritability, worthlessness, hopelessness, agitation, and guilt are present for 2 
weeks or longer, with some of these symptoms escalating to suicidal and homicidal 
ideations (American Psychiatric Association [APA], 2013).  
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The United States’ mental health system faces difficulties related to screening and 
treating depression and other psychiatric disorders. Depression is one of the leading 
causes of medical disability worldwide, costing the healthcare system over $210 billion 
annually (Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015; World Health 
Organization [WHO], 2014). Over 16 million adults in the United States experienced at 
least one major depressive episode during 12 months in 2016 (NIMH,2017). Depression 
in the United States and worldwide has both indirect and direct effects on morbidity and 
mortality (Smithson & Pignone, 2017). According to WHO (2015b), moderate to severe 
depression can lead to comorbidities such as heart disease, diabetes, and stroke. It can 
also affect productivity at work, socialization, increased absenteeism, healthcare costs, 
and suicidal tendencies.  
The U.S. Preventive Services Task Force (USPSTF) recommended screening all 
patients for depression irrespective of their risk factors (USPSTF, 2016). They state that 
screening for depression improves the accuracy of early detection (Siu, 2016) and can 
significantly improve overall health outcomes (Culpepper, Muskin, & Stahl, 2015). 
According to the USPSTF guidelines, patients should be appropriately screened, 
diagnosed, treated, and provided follow-up for depression. According to Gay, Kottorp, 
Lerdal, & Lee (2016), failure to recognize depression can cause danger to the patient and 
the community. Haefner, Daly, & Russell, (2017), listed several depression screening 
tools available, such as (a) Hamilton Depression Rating Scale, (b) Zung’s Self-Rating 
Depression Scale, (c) Patient Health Questionnaire-9 (PHQ-9), (d) Beck Depression 
Inventory and Beck Depression Inventory-II, (e) Montgomery-Asberg Depression Rating 
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Scale, (f) Cornell Scale for Depression, (g) Center for Epidemiologic Studies Depression 
Scale, (h) Brief Depression Scale, and (i) Multi-Problem Screening Inventory Depression 
Subscale. (Haefner et al., 2017). Of these, the PHQ-9 is the most recognized and 
reputable diagnostic screening tool, which is recognized to be efficient and accurate in 
the initial detection of depression (Haefner et al., 2017). The PHQ-9 has also been shown 
to be a reliable and valid tool that has been described as a simple, easy-to-use nine-
question survey that helps clinicians screen and diagnose depression to make informed 
decisions regarding patient treatment (Brody, Pratt, & Hughes, 2018). The PHQ-9 is the 
most validated tool in mental health used by providers to diagnose depression and 
monitor treatment response.  
The PHQ-9 screening tool aligns with the APA’s Diagnostic and Statistical 
Manual of Mental Disorders (5th ed., DSM-V) criteria for major depressive disorder, 
guiding the provider to accurately diagnose and manage depression (APA, 2013). Despite 
the prevalence of depression in the United States and unambiguous guidelines regarding 
the use of the PHQ-9, providers continue to struggle to implement this depression 
screening tool in their practice (NIMH, 2017). 
The nature of this project was to educate providers on the use of the PHQ-9 
depression screening tool to increase their usage, knowledge, and confidence level to 
diagnose and manage depression in the outpatient clinic. The social change implications 
noted were reflected in the increase the providers stated they had in both their knowledge 
and confidence level, which can facilitate appropriate diagnosis and treatment, promote 




The project took place at an outpatient clinic located in a large Southern state. The 
clinic inconsistently uses the PHQ-9 tool for depression screening, which is incorporated 
in the electronic medical records (EMR) for documentation when it is completed. The 
DNP project was developed because of an informal meeting with the clinical team, which 
included the chief psychiatrist, the office manager, and a provider. During the meeting, 
the clinical staff presented the data they had collected via an anonymous form from their 
quality improvement report. The clinical team indicated that not every patient with a 
diagnosis of depression had been screened by providers using the PHQ-9 screening tool. 
The clinical team identified the gap in practice as being a perceived lack of knowledge 
and confidence level in implementing the PHQ-9 depression screening tool by providers 
when they were providing care to their patients. The clinical team also reported a 
persistent decline in the use of PHQ-9 screening tool by the clinic in the past 2 years. 
They reported a 50% usage, which was below the national average of 60%. The 
recommended standard for screening patients using PHQ-9 tool is 100% for all providers 
(USPSTF, 2016).  
The team also indicated that there was no formal educational module in place on 
the use of PHQ-9 depression screening tool, and as a result, the providers did not fully 
understand how to properly diagnose and manage depression, which led to many patients 
not getting appropriate treatment or proper follow-up. The consistently low percentage of 
the use of PHQ-9 by providers in managing depression convinced the clinical team there 
was a need to educate. This gap in practice was addressed in this project with the goal of 
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having no patient with a missed diagnosis because of lack of appropriate testing (see Siu, 
2016; USPSTF, 2016). By improving the provider’s knowledge and confidence level on 
the use of PHQ-9 screening tool, a positive treatment outcome was expected, as well as 
achieving the public health task of early identification of depression (Porter, 2017).  
The significance of this educational project is that it would increase providers’ 
knowledge and confidence level in the use of PHQ-9, making it easy to identify and 
manage depression, which would significantly improve the patients’ overall health 
outcomes (Culpepper et al., 2015). The USPSTF (2016), indicated that properly 
screening for depression could be effective in improving patient treatment outcomes. The 
importance of educating providers to attain competency in using depression screening 
tools cannot be overstated (Abar, Hong, Aaserude, Holub, & DeRienzo, 2016). Despite 
the prevalence of depression in the United States and clear-cut guidelines regarding the 
use of the PHQ-9, providers continue to struggle to implement this depression screening 
tool in their practice (NIMH, 2017). 
The significance to the nursing profession is demonstrated by the fact that 
educating providers would not only increase their clinical knowledge but also increase 
their confidence level and opportunities to practice in an autonomous fashion when 
treating patients with depression. It would potentially increase their patients’ positive 
outcomes by promoting better health and mental well-being. Educating providers on the 
use of PHQ-9 could improve the lives of their patients and prevent suicide.  
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Purpose of the Project 
The gap in practice was a lack of knowledge and confidence level in the providers 
as it pertained to the use of the PHQ-9 screening tool. As a result, the DNP project’s 
intended goal was to educate providers by implementing an educational program with an 
aim to increase the usage of the PHQ-9 screening tool. A secondary goal was to improve 
the providers’ confidence level in the use of this screening tool for the management of 
depression. This DNP project answered the following practice-focused question:  
PFQ: In providers managing depression in an outpatient psychiatric clinic, does 
education on using the PHQ-9 tool increase staff knowledge and confidence level 
immediately after the educational intervention and again in 1 month?  
This doctoral project had the potential to address this gap in practice by 
promoting better patient outcomes through early diagnosis and treatment of depression. It 
will teach the providers how to administer the PHQ-9 and why it is important to use this 
tool when assessing patients who appear to be depressed with the goal of appropriate 
treatment and follow-up. Completion of this doctoral project should also increase nurse 
providers’ confidence levels when assessing and treating those with depression. The goal 
was that providers better understand the benefits of using the PHQ-9 tool.  
Nature of the Doctoral Project 
I obtained the sources of evidence from the following scholarly databases: 
Medline, CINAHL, EBSCO host, Ovid Plus, Walden University library, Google Scholar, 
and Pub Med. I performed a search related to the project topic and reviewed the current 
literature. I examined a total of 750 articles. The search was limited to studies published 
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in English from 2010 to 2018. The number was reduced to 60 articles with 10 selected as 
relevant to the clinical setting. The final articles selected were published within 5 years of 
my expected graduation date. The Iowa model guided the development of the educational 
project.  
A pretest was done prior to implementing the educational module to evaluate 
providers’ knowledge on the use of PHQ-9 tool. The educational session was completed 
using a PowerPoint educational module. A posttest was completed by participants 
immediately after the educational training and another posttest was administered 1 month 
after. I analyzed the results by the Statistical Product and Service Solutions (SPSS) 26.0 
software. The gap in practice identified by the clinical team was the lack of knowledge 
and confidence level using the PHQ-9 screening tool by providers at the clinic to 
accurately diagnose and manage depression.  
The purpose of the DNP project was to develop, deliver, and evaluate an 
educational program for care providers regarding use of the PHQ-9 screening tool for the 
identification of depression. The gap-in-practice was addressed by the creation of a staff 
educational program that improved staff knowledge and confidence level on the use of 
PHQ-9 screening tool for the identification of depression. This should contribute to better 
patient outcomes that will include early detection of depression, appropriate treatment, 
and proper follow-up as the providers understand the reasons for using the PHQ-9 tool.  
Significance 
The stakeholders impacted by the project included the patients, who could 
potentially have better patient outcomes due to early diagnosis and treatment of 
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depression. Other stakeholders included the families of the patients. Healthcare providers 
who benefit from the educational sessions by acquiring increased knowledge and 
confidence would also be stakeholders. 
This project contributes to improving the providers’ knowledge and confidence 
level on the use of PHQ-9 during patient visits, resulting in early detection of depression 
and positive psychopharmacological outcomes. Early detection plays a major role in the 
outcome of any health issue (Porter, 2017). Potential contributions to nursing practice 
would include me being able to share the results of the project with other nurses by 
presenting at conferences and by publishing. Nursing practice would also benefit by 
increased knowledge about the PHQ-9 and the benefits of its use. The educational project 
improved providers’ knowledge and confidence levels promoting proper use, accurate 
screening, prompt identification of depression, and management of depression.  
This educational project can be easily transferred to similar practice areas such as 
a primary care clinic. Even though it was designed for this outpatient clinic, the 
evidenced-based educational program can be used to educate providers practicing in 
primary care settings to improve their knowledge and confidence level in using PHQ-9 
depression screening tool to manage patients with depression.  
Implications for social change would be reflected by a potential decrease in the 
rate of undiagnosed depression, which can derail lives, the prevention of suicide by 
depressed patients who are now being properly treated, and hopefully a more accepting 
attitude of clinical depression by better understanding the prevalence of it. The PHQ-9 
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screening tool could be used at other outpatient clinics that work with patients being 
treated for depression.  
Summary 
The first section of the project paper discussed the DNP practice problem, project 
purpose and question, and the significance to nursing. I also briefly discussed the 
methodology and the implications for social change. The next section builds on the 
foundation of the prior section, and examines the background and context of the project, 
covering the literature review and theoretical framework in pursuit of developing an 
educational program for providers to encourage the use of the PHQ- 
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Section 2: Background and Context 
Introduction 
The practice problem identified at this outpatient clinic was that providers 
struggled with the consistent use of the PHQ-9 screening tool to identify and manage 
depression in their patients. The clinical team reported a 50% average use of the PHQ-9 
screening tool by providers at the clinic, which is below the national average of 60%. The 
clinic does not have any formal educational module in place on the use of PHQ-9 
depression screening tool to accurately diagnose and manage depression leading to many 
patients not getting appropriate treatment or proper follow-up. This DNP project 
answered the practice-focused question:  
PFQ: In providers managing depression in an outpatient psychiatric clinic, does 
education on using the PHQ-9 tool increase staff knowledge and confidence level 
immediately after the educational intervention and again in 1 month.?  
The main purpose of the DNP project was to develop, deliver, and evaluate an 
educational program for providers on the PHQ-9 screening tool for the identification of 
depression. A secondary purpose was to improve the providers’ confidence level in the 
use of this screening tool for the management of depression. For depression screenings to 
be correctly and consistently performed, it becomes imperative for providers to be 
appropriately educated on using the PHQ-9 depression-screening tool and gain 
confidence in doing so. 
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Concepts, Models, and Theories 
The Iowa evidence-based practice (EBP) model was used to guide the project. 
The rationale for using the Iowa model lay in the fact that it is an evaluation model that 
supports a project designed to educate providers and works well with the goal of building 
confidence levels. This model provides guidance to providers in everyday decision-
making to provide quality patient care (Grove, Burns, & Gray, 2013). The Iowa model 
provides opportunities for the providers to pay attention to knowledge and to question 
existing nursing practices to see if they can be improved upon by using current research 
findings (Buckwalter et al., 2017). The Iowa model guide was initially used at the 
Federally Qualified Health Center site in Brooklyn by the clinical nursing staff in 
adopting an evidence-based depression protocol, clinical guidelines for the PHQ-2 and 
PHQ-9, and an EBP educational curriculum plan (Doody & Doody, 2014). The Iowa 
model focuses on EBP through a structural viewpoint rather than from an individual’s 
point of view, which provides guidance for decision-making to help provide quality care 
(Grove et al., 2013). Using this Iowa model (see Appendix A) assists the providers to 
question their existing practice and see if they can improve their knowledge and 
confidence level using current research findings (Buckwalter et al., 2017).  
According to Dentje (2015), the first step of the Iowa model is to identify the 
problem that needs to be changed by identifying the clinical practice question, which is 
triggered by a problem in the setting. If the problem is a priority, then a team is formed to 
start searching for relevant literature related to the recognized problem. With insufficient 
evidence, an additional literature search is necessary. The second step is to test the 
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practice change (Brown, 2014). If successful, then the change can be implemented into an 
organizational practice change with a continuous evaluation of the change after 
implementation (Brown, 2014). Providers at the clinic manage patients with depression. 
However, increasing the knowledge and confidence levels of providers regarding using 
the PHQ-9 tool to manage their depression would result in a better treatment outcome.  
Synthesis of the Literature 
A literature search provided an overview of evidence indicating that effective 
staff education modules can increase providers’ knowledge and confidence levels in 
using the PHQ-9 screening tool to diagnose and manage depression in a clinical setting. 
The literature review also provided a guide to developing the educational module used to 
educate the provider on the use of PHQ-9 screening tool. The USPSTF (2016) suggested 
that properly screening for depression could be effective in improving patient treatment 
outcome, improving the accuracy of early detection, and significantly improving overall 
health outcomes. The literature review by Abar et al., (2016) also emphasized that 
effective treatment of depression is based on proper screening and diagnosis of patient 
symptoms. Therefore, the importance of educating providers to attain competency in 
using depression screening tools cannot be overstressed.  
A comprehensive review of current scholarly literature on the decreased use of 
and poor adherence to the PHQ-9 offered insights into the background of this problem, 
the significance of the problem, evidence-based interventions to address the problem, and 
evidence-based approaches to evaluate the project (Peterson et al., 2018; Terry, 2018). 
Horton and Perry (2016) also conducted a study to determine the effectiveness of the 
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PHQ-9 by evaluating its rating scale. The PHQ-9 was developed based on classical test 
theory, the limitations of which include the fact that “data are treated as interval level, the 
evaluations of scales are sample dependent, and the assumptions of CTT cannot be 
formally tested” (Horton & Perry, 2016, p. 237). As a result of these limitations, Horton 
and Perry introduced a new form of psychometric methodology to evaluate the PHQ-9: 
the Rasch analysis. In a sample of 767 depressed patients, the researchers used the Rasch 
analysis to test the outcomes of the PHQ-9 against a subjective mathematical model. The 
result was a formal measurement process for screening depression using PHQ-9, the 
benefit of which was to confirm the use of cut scores and clinical questions as necessary 
to produce more accurate results. Horton and Perry’s examination confirmed that the 
PHQ-9 is an important and reliable tool for screening depression but that it should not be 
used alone if a primary care provider wants to get the best possible results. The results of 
the Horton and Perry study are supported by Picardi et al. (2016), which established that 
the PHQ-9 is not used for outcome evaluation only. The researchers tested the outcomes 
of the PHQ-9 to determine whether its results can be improved. They were directed by 
research questions that sought to determine which features of a screening program can be 
improved.  
The USPSTF (2016) recommend providing adequate education to providers to 
increase the compliance in using the PHQ-9 screening tool. By improving providers’ 
knowledge and confidence levels on the use of PHQ-9 screening tool this would have a 
positive treatment outcome as well as achieve the public health task of early detection of 
depression, which is widely not recognized and often not getting treated. (Porter, 2017).  
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The literature review uncovered evidence used to build the education program and 
answer the practice-focused question. Beard, Hsu, Rifkin, Busch, and Bjorgvinsson 
(2016) supported the use of the PHQ-9, explaining that it allows for a two-category 
assessment of the symptoms of depression: somatic symptoms, including overeating, 
poor appetite, low energy, and fatigue; and cognitive-affective symptoms, including 
feeling hopeless or discouraged.  
The PHQ-9 has been validated in primary care environments and used 
successfully in behavioral health centers. The PHQ-9 depression tool can be self-
administered or administered by a clinician. Providers use PHQ-9 during initial visit to 
assist with diagnosis and identification of problem symptoms and follow up visits to 
measure treatment response and identify specific symptoms that are not responding 
(APA, 2013). The PHQ-9 was developed by Kroenke, Spitzer, Williams, and Löwe 
(2010) with an educational grant from Pfizer, Inc., and it is adapted from the Primary 
Care Evaluation of Mental Disorders. There is no permission needed to reproduce, 
translate, display, or distribute the PHQ-9 (Kroenke et al., 2010).  
In several studies, the PHQ-9 scores > 10 have been shown to have a sensitivity 
of 88% and a specificity of 88% for major depressive disorder (APA, 2016). A cross-
sectional study by Seo and Park (2015) involving 132 participants who visited the clinic 
as a result of headaches resulted in the authors collecting their data from patients 
suffering from migraines who were 16 years old to 70 years old in order to validate the 
PHQ-9 depression screening tools. The study reported that the use of PHQ-9 tools was 
reliable and valid with a sensitivity of 79.5%, and specificity of 81.7% with a positive 
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predictive value of 64.6%. The study reported a negative predictive value of 90.5%. This 
study concluded that the PHQ-9 is a reliable and valid tool for screening for depression in 
an outpatient clinic. Several independent research studies have indicated that using the 
PHQ- 9 depression-screening tool after education could promote early diagnosis and 
prompt referral and management of depression (Seo & Park, 2015).  
Educating providers on the use of PHQ-9 is important in today’s evolving 
healthcare system may greatly improve patient treatment outcomes and overall quality of 
care (DeCapua, 2018). To this effect, it is crucial for providers to receive proper 
education on the use of PHQ-9 to manage depression in an outpatient clinic. My 
extensive literature review guided the development of an educational module that can 
effectively impact providers’ knowledge, confidence levels, and patient outcomes.  
Relevance to Nursing Practice 
The relevance of this educational module to nursing practice and healthcare, in 
general, can be established by the prevalence of depression worldwide. In the United 
States, approximately 16 million patients had experienced at least one major depressive 
episode during 12 months in 2016 (NIMH, 2017). Despite the prevalence of depression in 
the United States and clear-cut guidelines regarding the use of the PHQ-9, providers 
continue to struggle to implement this depression screening tool in their practice (NIMH, 
2017).  
According to the current states of nursing practice, unidentified depression can 
cause danger to the patient and their community, suggesting that patients should be 
appropriately screened, diagnosed, and treated for depression (Gay et al., 2016). 
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Untreated depression is a progressive mental health disorder that can result in severe 
disability, frequent emergency room visits, expensive hospitalizations, suicide, and low-
quality rating for the clinic. Depression has both indirect and direct effects on morbidity 
and mortality (Smithson & Pignone, 2017).  
The involvement of stakeholders is important to promote success in an 
educational project because of the feedback they provide, which adds value to the project. 
The USPSTF released a standard recommendation encouraging all providers to undergo 
regular depression screening education (DeCapua, 2018). The outcome of this 
educational module is meant to cause an increase in providers’ knowledge and 
confidence levels in using the PHQ-9 depression screening tool in clinical settings. The 
PHQ-9 is a validated screening tool, the use of which results in improved knowledge and 
skills related to the best clinical practice outcomes, reduced visit times, improved staff 
understanding of depression, and promotion of consistent follow-up among providers 
(Thombs et al., 2014). 
The involvement of the clinical team was vital to the success of this educational 
project because their contribution and feedback made it valuable to the clinic providers. 
Educating providers on the use of the PHQ-9 screening tool would improve their 
knowledge and confidence level, which would help reduce the incidence rate of a missed 
depression diagnosis in patients who visit the clinic.  
Current Strategies and Practices to Address the Gap in Practice 
Funderburk, Crasta, and Maisto, (2016) mentioned that the Veterans Health 
Administration (VHA) successfully implemented standardized annual screening for 
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depression. Being a large healthcare facility, they mandated the use of PHQ-2 and PHQ-
9, as the screening measures in the implementation of clinical practice guidelines for 
major depressive disorders. The current strategy to address the gap in practice is 
developing an educational project for providers on the use of PHQ-9 screening tool that 
will increase their knowledge and confidence level. Increasing the providers knowledge 
and confidence level will make it easy to identify and manage depression which would 
significantly improve the patients’ overall health outcomes (Culpepper et al., 2015). 
According to Seo & Park, (2015), there are different research studies suggesting that 
utilizing the PHQ- 9 depression-screening tool, after educating the providers, could 
promote early diagnosis and prompt referral and management of depression. By 
improving provider’s knowledge and confidence level on the use of PHQ-9 screening 
tool this would have a positive treatment outcome, as well as achieving public health task 
of early detection of depression which is widely not recognized and not getting treated. 
(Porter, 2017). Currently at the facility where the project intervention will occur, there is 
no consistent usage of the PHQ-9 and providers state they do not feel confident in 
administering. This project should close that gap in practice.  
Advances to Nursing Practice 
The gap in practice at this clinic revealed there a 50% average use of the PHQ-9 
screening tool by providers at the clinic which is below the national average of 60% and 
the clinic does not have any formal educational module in place on the use of PHQ-9 
depression screening tool to properly diagnose and manage depression leading to many 
patients not getting appropriate treatment or proper follow-up. The clinical relevance of 
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this project was to educate the provider on the use of PHQ-9 screening tool, which will 
improve their knowledge and confidence level to diagnosis of depression early and 
provide treatment. (Hamid & MacKenzie, 2017). The USPSTF released a standard 
recommendation encouraging all providers to undergo regular depression screening 
education (DeCapua, 2018). Educating providers on the use of PHQ-9 is important in 
today’s evolving healthcare system as it greatly improve patient treatment outcomes and 
overall quality of care (DeCapua, 2018). 
Local Background and Context 
This staff education project was conducted in an outpatient clinic located in the 
southern United States where providers struggle with the use of PHQ-9 screening tool to 
identify and manage depression in their patients. The clinic has a population of 
approximately 600 patients, ages 18 and older. All adult patients are eligible for 
healthcare services at the clinic. The clinic has an average caseload of 120 patients per 
day. It employs EMRs for documentation purposes. The staff of the outpatient clinic 
consists of two psychiatrists, one office manager, two medical assistants, and six 
advanced practice RNs. The clinic provides care to all ethnic’s backgrounds and 
socioeconomic background. The target audience for the DNP project is the providers in 
the clinic because of the lack of knowledge and confidence level in using PHQ-9 
depression screening tool.  
The local evidence on the relevance of the problem is that providers are not 
educated properly on the use of PHQ-9 screening tool because the clinic does not have a 
formal education module. There is a consistently low percentage of the use of PHQ-9 by 
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providers in managing depression convinced the clinical team there was a need to 
educate. This gap in practice was addressed in this project, with the goal of having no 
patient with a missed diagnosis because of lack of appropriate testing (Siu & USPSTF, 
2016). At the clinic, it has been found that the impact of disability or depression affects 
not only the patient, but also affects their family, friends, & the community.  
The institutional context as applicable to the problem is the fact that, the clinical 
team was concerned about the 50% average rate, compared to the national average of 
60%, on the usage of PHQ-9 screening tool in managing depression. This justifies the 
practice-focused question:  
PFQ: In providers managing depression in an outpatient psychiatric clinic, does 
education on using the PHQ-9 tool increase staff knowledge and confidence level 
immediately after the educational intervention and again in 1 month.?  
The current providers will be educated to be able to teach new providers being hired in 
the clinic on the use of PHQ-9 screening tool. The increased occurrence of depression 
within the U.S. population leads to a social and economic concern (CDC, 2013; 
Greenberg et al., 2015). Therefore, screening local patients for depression using the PHQ-
9 is important because lack of proper screening for depression by providers can lead to 
untreated disease, which can lead to adverse outcomes like suicide. The importance of 
examining this topic is because depression is one of the leading causes of medical 
disability worldwide, costing the healthcare system over $210 billion annually and, like 
the local agency, the United States’ mental health system faces difficulties related to 
screening and treating depression and other psychiatric disorders. (Greenberg et al., 2015; 
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WHO, 2014). The impact of depression affects does not only affect the patient, but it also 
affects their family, friends, & their community and is not always measurable. At the 
psychiatric outpatient where the project was implemented, it was found that properly 
identifying patients with depression using the PHQ-9 screening tool is important to 
initiate appropriate treatment.  
Role of the Doctor of Nursing Practice Student 
I had no professional relationship with the proposed project site and worked 
closely with the clinical team to develop the evidence based educational strategy, 
implement and evaluate the program. The clinical team presented the data to the DNP 
student related to the gap in practice after reviewing the EMR for patients with diagnosis 
of depression to see if the providers utilized the PHQ-9 screening tool to screen for 
managing their depression. 
My role in this DNP project included developing, implementing and evaluating an 
education module on the use of PHQ-9 depression-screening tool for six providers who 
work in clinic settings that could increase their knowledge and confidence level in 
managing depression. I also designed a pre/posttest questionnaire to evaluate the 
providers’ knowledge on the use of PHQ-9 screening tool. The DNP student made 
changes to the educational module based on feedback and then presented the program to 
the six participants. The DNP student completed a pretest before the initiation of the 
educational program to find out the gap in knowledge, and confidence level in using 
PHQ-9 and presented the program to the six participants who are providers at the clinic. 
The DNP student collected and analyzed the data and the resulting conclusions.  
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My motivations for this doctoral project was to implement an educational 
program that would have a difference in the lives of the mentally ill and the families and 
communities in which they live. I have seen is the devastation that severe depression can 
cause on a patients’ emotional health, and I desired to work with the clinical team to 
implement an educational program for the providers, since they had identified a problem 
from their quality report.  
The only bias was the fact that the PHQ-9 screening tool was the only tool 
approved by the clinic to diagnose and manage depression by providers, and the one I 
was most familiar with. There was an internal bias toward the PHQ-9 when the 
possibility exists that another tool may have been better accepted by the providers.  
The Role of the Project Team 
The clinical team collected and provided data from their quality report, which 
indicated a gap in practice in this clinic. The clinical team also provided support for this 
staff education module by assisting with problem identification. They presented the data 
from the quality report, which they made available to this DNP learner. The clinical team 
assisted with the review and analysis of the literature and identified the areas that needed 
education and reviewed the pre-post-test survey. They identified the areas of needed 
education based from their quality report.  
Summary 
This section appraised the background of the project implementation site. It 
discussed the use of Iowa EBP model to guide the implementation of the project and the 
relevance to nursing practice. This section also identified and defined the roles of the 
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various parties involved in the project, including the role of this DNP learner. The next 
Section includes a discussion of the evidence supporting the project. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
According to the USPTF, screening for depression improves the accuracy of early 
detection (Siu, 2016) and improves overall health outcomes (Culpepper et al., 2015). 
Despite the prevalence of depression in the United States and definite guidelines 
regarding the use of the PHQ-9, providers continue to struggle to implement this 
depression screening tool in their practice (NIMH, 2017).  
The main problem identified was the lack of knowledge and self-confidence on 
the use of PHQ-9 screening tool to diagnose and manage depression at a local facility. 
The purpose of the DNP project was to develop, deliver, and evaluate an educational 
intervention that addresses the management of depression using the PHQ-9 screening tool 
as an instrument to identify patients suffering from depression. Screening for depression 
using the PHQ-9 tool routinely by providers at the clinic provides a great opportunity to 
better diagnose and manage depression. According to the statistics provided by USPFTF 
(2016), approximately 16.2 million people in the United States suffer from depression 
with another 35 million having experienced depression at some point in their lives. The 
objective of this DNP project was to develop and implement an evidenced-based 
educational module on the use of PHQ-9 tool to enhance providers’ knowledge and 
confidence levels in managing depression in the outpatient clinic. The clinical team 
provided the DNP student with expert opinions and recommendations in determining the 
practicality, applicability, and the relevance of the staff education module in addressing 
the gap in practice at the clinic. I used the Iowa EBP model to guide this project’s 
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objective; the model contributed to both the planning and implementation of the 
educational module. In Section 3, I examine sources of evidence to support the project 
and analysis and synthesis of the data.  
Practice-Focused Question  
The local problem was the perceived lack of knowledge and confidence level in 
using the PHQ-9 depression screening tool by providers at an outpatient clinic when 
providing care to their patients who may suffer from depression. The DNP project 
answered the following practice-focused question:  
PFQ: In providers managing depression in an outpatient psychiatric clinic, does 
education on using the PHQ-9 tool increase staff knowledge and confidence level 
immediately after an educational intervention and again in 1 month?  
The purpose of this DNP project was to improve provider knowledge and confidence in 
using the PHQ-9 depression screening tool. The approach aligns with the practice-
focused question as it was expected that through provider education, there will be 
improvement in knowledge and confidence using the PQH-9 tool. 
Sources of Evidence 
The sources of evidence used for the project were Medline, CINAHL, EBSCO 
host, Ovid Plus, Walden University library, Google Scholar, and Pub Med. The keywords 
used were depression, depression screening in outpatient clinic, types of depression 
screening, depression-screening guidelines, depression screening recommendation, 
evidence-based clinical practice for depression, theories, staff education training, 
depression module, and validity and reliability of the PHQ-9 depression screening tool.  
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The initial search yielded a total of 750 articles. Narrowing the search to articles 
published in English from 2010 to 2018 reduced the number to 60 articles. Ten articles 
that were relevant to the project question and the clinical setting were selected and used 
for the project. These ten articles selected provided appropriate evidence to address the 
practice-focused question. Studies not included in the selections were those written in 
indigenous languages, those involving children younger than the age of 18 and those that 
did not align with the USPSTF recommendations. The collected evidence-based 
information was used to design and implement the educational module to improve 
providers’ knowledge and confidence in using the PHQ-9 screening tool to help to bridge 
the gap in practice and meet providers’ needs at the clinic.  
Analysis and Synthesis 
The review of literature and analysis answered the practice question and provided 
a guide to achieve the purpose of this project. The USPSTF (2016) recommended 
screening everyone for depression. Based on the data reported by the clinical team, only 
50% of the patients were screened using the PHQ-9 tool, which is below the national 
average of 60%. The above data from the clinic is below the USPSTF standard 
requirement of 100% for all providers (USPSTF, 2016). The review and analysis of 
evidence base literature supported the purpose of this educational program, which was to 
increase knowledge and confidence level in providers at the clinic. Primeau, Avellaneda, 
Musselman, St. Jean, and Illa (2013) supported the idea that the more providers assess 
and treat depression using the PHQ-9, the more likely patients are to ultimately have 
lower depression screening scores, leading to improved health outcomes and increased 
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quality of life. It was also noted that the use of PHQ-9 screening tools by providers in an 
outpatient clinic is vital in diagnosing and managing depression.  
USPSTF (2016), indicated there is evidence suggesting that screening for 
depression plays a vital role in early identifying and better treatment outcome. They also 
found enough evidence supporting that there is no harm of screening for depression. 
NIMH (2017) also highlighted that frequent use of the PHQ-9 tool by providers can 
identify symptoms of depression early, enhance early treatment interventions, and limit 
the potential for devastating complications. NIMH (2017) also indicated that many 
successful suicides were carried out by patients who consulted health professionals the 
week prior to their death. One important objective of this DNP project was to ensure that 
providers of the facility obtained evidenced based education that can help them utilize the 
PHQ-9 tool more consistently and boost their confidence level in using the tool.  
Based on the literature review and analysis, USPSTF (2016) reported a negative 
impact of the lack of education on the use of PHQ-9 screening tool to diagnose and 
manage depression. PHQ-9 has been identified as a reliable and valid tool for screening 
for depression in an outpatient clinic (Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, 
J., Kerse, N., Fishman, T., . . . Hatcher, S., 2010). Several independent research studies 
have indicated that using the PHQ- 9 depression-screening tool after educating the 
healthcare providers promotes early diagnosis and prompt management of depression 
(Seo & Park, 2015). According to Williams, Chung, & Muennig, (2017), depression is 
identified as a contributing factor to increased disability globally, costing the United 
States in 2016 approximately $233 billion dollars. The effect of depression to the 
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economy results from increased medical care use, lower quality of life, and decreased 
workplace productivity (Williams et al., 2017). NIMH (2017) also reported that more 
than 16 million adults in the United States had experienced at least one major depressive 
episode during 2016. Failure to recognize depression can cause danger to the patient and 
the community according to USPSTF guidelines, suggesting that patients should be 
appropriately screened, diagnosed, and treated for depression by providers in the clinic 
(Gay et al., 2016). Despite the prevalence of depression in the United States and clear-cut 
guidelines regarding the use of the PHQ-9, providers continue to struggle to implement 
this depression screening tool in their practice (NIMH, 2017).  
After comparing, contrasting, and synthesizing the literature, I concluded that the 
use of PHQ-9 screening tools by providers in an outpatient clinic is vital in diagnosing 
and managing depression. Educating providers on the use of PHQ-9 is important in 
today’s evolving healthcare system as it greatly improves patient treatment outcomes and 
overall quality of care (DeCapua, 2018). To this effect, it is crucial for providers to 
receive proper training on the use of PHQ-9 to manage patients’ depression in an 
outpatient clinic. The literature review guided the development of an educational module 
that effectively and positively impacts the providers’ knowledge, confidence level, and 
patient outcomes.  
Participants 
All six participants in the staff educational program were advanced practice RNs 
providers at the clinic. The project took place in an outpatient clinic. The participants 
were educated about the nature of the project. The approach for this evidence-based staff 
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education project was to support the organization in the implementation and evaluation of 
an educational program on the use of the PHQ-9 screening tool via provider pre- and 
posttests. Participation in the educational project was voluntary. The criteria for inclusion 
of the clinical team members included their specific knowledge and years of experience 
in their field of practice. The clinical team for consultation for the creation of the 
educational program consisted of the chief psychiatrist, the office manager, the medical 
director, a nurse practitioner, and a staff nurse. All members of the clinical team had at 
minimum 10 years of experience in the field of psychiatry. As the DNP project leader, I 
have 6 years of experience as a family nurse practitioner and 1 year as a psychiatric nurse 
but have worked in the field of psychiatry for 20 years in various roles. Participants were 
not identified by name or any other specifying information for use in the educational 
project. All the participants were notified and assured that all information was 
confidential.  
Procedure  
A background analysis of the clinic’s strategy of using the PHQ-9 was completed. 
A signed site agreement for permission for the project to be done in the facility was 
attained. After approval from the Walden Institutional Review Board (IRB), six 
participants who are advanced practice RNs participated in the project. Participation was 
voluntary and each participant could withdraw from the project at any time. Gaps in the 
facility’s current strategies in addressing depression were identified and used to develop 
the educational training.  
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The clinical team had previously collected and provided data from their quality 
report indicating a gap in practice in this clinic. The current process in place for using the 
PHQ-9 screening tool at the clinic was analyzed. The project clinical team and I agreed 
on the content of the educational presentation. I led the development of the educational 
program. The team reviewed and analyzed the literature and identified the areas that 
needed education. The outline of the educational intervention was developed and 
validated by the team. I was provided with expert opinions and recommendations in 
determining the practicality, applicability, and the relevance of the staff education 
module in addressing the practice gaps at the clinic. The Iowa EBP model was used to 
guide the project’s objective and contributed significantly to both the planning and 
implementation of the educational module. The outcome of the needs’ assessment was 
used as a guide in developing and implementing the educational module. A 45-minute 
PowerPoint educational intervention addressed the gaps identified regarding use of the 
PHQ-9 depression screening tool at the clinic. Recommendations on the content of the 
educational module were developed. A draft of the questionnaire reviewed for clarity, 
appropriateness of the content, format, and style was competed.  
The educational program consisted of a 45- minute PowerPoint presentation to 
educate the participants on the use of PHQ-9 screen tool to diagnose and manage 
depression in an outpatient clinic (Appendix F). The PHQ-9 tool (Appendix F) was 
developed by Kroenke et al. (2010) with an educational grant from Pfizer Inc and it is 
adapted from the Primary Care Evaluation of Mental Disorders. There is no permission to 
reproduce, translate, display, or distribute the PHQ-9 (Kroenke et al., 2010). The PHQ-9 
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scores > 10 have been shown to have a sensitivity of 88% and a specificity of 88% for 
Major Depressive Disorder. PHQ-9 screening tool was both valid and reliable in 
depression screening (APA, 2016). The instruments used in this project were a 13-
question pre- and post-test that tested the participant’s knowledge and confidence level 
on the use of depression screening tool (Appendix D). The questionnaire included three 
demographic and 10 Likert-type questions. The 10 Likert-type questions were designed 
to probe participants to express their perception on their knowledge and confidence of 
using the PHQ-9 tool. The pre/posttest was designed as a Likert type questionnaire in 
which the participants had the opportunity to quantify their perception before and after 
the educational intervention. The questions were developed using a 5-point Likert type 
rating scale from strongly agree = 1 to strongly disagree = 5: strongly agree (5 points), 
agree (4 points), neutral (3 points), disagree (2points), and strongly disagree (1point). The 
clinical team reviewed the draft of the questionnaire for clarity, appropriateness of the 
content, format, and style. The nature of the project was explained to the participants 
before the pretest. They were required to sign a consent to participate in the project. The 
pre implementation data was collected using the pretest questionnaire. The PowerPoint 
was then presented to the participants. 
The six providers were required to sign a consent to participate in the project. The 
nature of the project was explained to the participants before the pretest. They completed 
the pretest in approximately 5-10 minutes providing a baseline for their knowledge and 
confidence level in using PHQ-9 tool prior to receiving the educational program. The 
PowerPoint presentation took 45 minutes and the post-implementation data was 
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immediately collected after the presentation with another data point collected one month 
after.  All the six providers at the clinic were present at the presentation. The pre/posttest 
questionnaire results remained confidential. 
The anticipated outcome of this educational program was for the participants to 
increase their knowledge and confidence level on the use of PHQ-9 depression screening 
tool. After the intervention, the results of the pre and posttest were presented to the 
clinical team. The data was analyzed using SPSS version 26 and the paired t- test was 
used to determine if differences in the means were statistically significant. The results 
were reported on a frequency table, descriptively and pie charts. The paired t-test was 
used to calculate the p-value and the standard deviation. The anticipated outcome of this 
educational program was for the participants to have increased knowledge and 
confidence level on the use of PHQ-9 depression screening tool. The results of the 
pre/posttest were presented to the clinical team. The outcomes from the project will be 
disseminated to another clinic.  
Protection of Human Subjects 
The project was on staff education: no patient intervention was included. 
Participant’s confidentiality and privacy was maintained throughout the project. 
Permission from the IRB at Walden University was granted and assigned approval 
number is 09-18-19-0409447. Providers participation was voluntary, and the participants 
were able to withdraw from the program at any time. All the data was deidentified and 
remains anonymous, and the participant questionnaires will be stored securely at the 
clinic for five years. The computer used by the DNP student was password protected. 
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Prior to their participation, each of the participants gave their consent to complete an 
anonymous questionnaire. A site agreement form was signed, and Walden IRB approval 
was obtained. The project implementation site did not require IRB approval. The clinic 
deferred to the university and accepted their IRB approval process. Outliers and missing 
information were unremarkable due to the small number of participants. 
Analysis and Synthesis 
The main goal for the DNP project was to develop, deliver, and evaluate an 
educational program for care providers regarding use of the PHQ-9 screening tool for the 
identification of depression in an outpatient clinic setting. The approach used was a 
quantitative method to analyze the data and present the results. The pretest/posttest was 
used to measure the outcome of the education and the data was analyzed using SPSS 26.0 
(2017) software. A descriptive analysis was used to report the results, while the 
utilization of the t-test was used for the analysis because the same subjects were being 
tested in different times (pre/posttest). The t-test is appropriate when we are trying to 
determine if the means of the 2 variables (pre/posttest) are statistically different or 
significant. The level of significant (p) is set at 0.5. The project did not have any control 
or experimental groups. 
Summary 
Providers have a vital role to play with regards to diagnosing and managing 
depression in an outpatient clinic. This section of the project discussed the doctoral 
proposal plan for collecting and analyzing the evidence with a well-defined source of the 
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evidence, description of how the data was collected, measured, and the ethical protection 
of the participants.  
In the next Section, a report on the statistical findings and implications that 
resulted from the analysis will be completed. Discussions of any unforeseen limitations 
or outcomes and their potential impact on the findings will be evaluated. The implications 
resulting from the findings and potential implications to social change will be discussed. 
Recommendations that will potentially address the gap-in-practice as indicated by the 
findings will be highlighted.  
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Section 4: Findings and Recommendations 
Introduction 
The problem addressed in this project results from the lack of knowledge and self-
confidence on the use of PHQ-9 screening tool to diagnose and manage depression by 
providers at an outpatient clinic. The DNP project answers the project-focused question:  
PFQ: In providers managing depression in an outpatient psychiatric clinic, does 
education on using the PHQ-9 tool increase staff knowledge and confidence in a 
1-month period?  
The purpose of the DNP project was to develop, deliver, and evaluate an educational 
intervention that addresses the management of depression using the PHQ-9 screening tool 
as an instrument to identify patients suffering from depression.  
The USPSTF (2016) recommended screening for depression irrespective of the 
risk factors. It was noted that at this local facility, the required standard for depression 
screening using the PHQ-9 tool was not met. They reported a 50% usage, which was 
below the national average of 60% and below the recommended standard for screening 
patients using PHQ-9 tool, which is 100% for all providers (USPSTF, 2016). This 
identified gap in practice created the purpose of the project, which was to educate 
providers and build their confidence in using the PHQ-9 screening tool in managing 
patients with depression. 
The validation for this project was obtained from two sources: the clinic and 
scholarly databases. The scholarly databases included Medline, CINAHL, EBSCO host, 
Ovid Plus, Walden University library, Google Scholar, and Pub Med. I performed a 
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search related to the project topic and reviewed current literature. I examined a total of 
750 articles. The search was limited to studies published in English from 2010 to 2018. 
The number was reduced to 60 articles with 10 selected as relevant to the clinical setting 
and depression management. 
Analytical strategies used for the staff development project were the Iowa EBP 
model and pretest and posttest evaluations before and after a PowerPoint educational 
program. For the project I used a quantitative method to analyze the data and present the 
results. I analyzed the pretest/posttest to measure of the outcome of the educational 
intervention using SPSS 26.0 software. I provided a descriptive analysis along with the 
quantitative method, including the use of the paired t test. The paired t test was used for 
the analysis because the same subjects were being tested in different times 
(pretest/posttest). The t test was used to determine if the means of the 2 variables 
(pretest/posttest) were statistically different or significant. The level of significant (p) was 
set at 0.5.  
Findings and Implications  
The clinical team collected and provided data from their quality report indicating 
a gap in practice in this clinic. A pretest questionnaire was used for this project to assess 
the providers’ knowledge and confidence levels in using PHQ-9 tool to diagnose and 
manage client depression. Providers were educated on the use of PHQ-9 depression 
screening tool to manage depression during a 45-minute PowerPoint presentation. A 
posttest was given to evaluate their knowledge and confidence levels immediately after 
education and again 1 month after the education. The outcome was measured using a 
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pretest and posttest analysis. A total of six providers in the clinic participated in the 
educational program. All six providers completed the pretests and post-tests. The staff 
educational program was developed to enhance provider knowledge and confidence 
levels on the use of PHQ-9 tool in diagnosing and managing depression. All six 
participants completed the consent form prior to the presentation of the educational 
program. The documents created were as follows: (a) Iowa Model of EBP (see Appendix 
A), (b) PHQ-9 ( See Appendix B), (c) Depression Toolkit (see Appendix C), (d) 
Knowledge/Confidence Level Questionnaire (see Appendix D), (e) Acknowledgement of 
Receipt and Review of PowerPoint Presentation( see Appendix E), (f) an educational 
curriculum plan (see Appendix F). The clinic had no routine depression screening 
practices in place at baseline. The results of the tests show a statistically significant 
difference between pretest score and posttest score on knowledge of PHQ-9. 
Evaluation of the Participants Knowledge 
In order to evaluate participants’ knowledge, I analyzed the results of the pretest 





Pretest Posttest Knowledge of Using the PhQ-9 Screening Tool in Depression 
Management 







P 1 8 20 20 
P2 10 19 20 
P3 12 16 20 
P4 4 19 19 
P5 17 20 20 
P6 8 19 20 








In order to assess the effectiveness of the educational intervention of the 
PowerPoint presentation on the use of PHQ-9 depression screening tool, a mean score of 
the participants were recorded before (µ = 9.8333) and after (µ = 18.8333) the 
intervention. The percentage change in the pretest/posttest scores were also computed 
using the formula [ change in % = (new mean - old mean) ÷ old mean × 100]. There was 
an average increase of 9 in the mean scores of the participants and a 92 % increase of 
knowledge from pretest to posttest. In order to evaluate if the change in the mean was 
statistically significant, the p-value was computed using the paired t test. The result (p = 
.005) was found to be statistically significant with α set at .05. Since p < α, this indicated 
that the intervention was successful. After 1 month, it was noted that an increase in the 
difference of the mean from 9 to 10 with a p value of .002 occurred, indicating further 
improvement in the average Likert scale score of the participants knowledge.  
Evaluation of the Participants Confidence Level 
In order to evaluate participants knowledge, the results of the pretest and the 
posttest were analyzed looking specifically at differences in confidence levels of the 





Pretest/Posttest on Confidence Level of using the PHQ-9 Screening Tool in Depression 
Management 
Participants  Pretest  Posttest 
Immediately After 
Intervention 
Posttest 1 month 
After Intervention 
P1 8 18 20 
P2 15 19 20 
P3 12 16 20 
P4 4 18 19 
P5 20 20 20 
P6 8 20 20 








In order to assess the effectiveness of the educational intervention on the 
confidence level, the mean score of the participants was recorded before (µ = 11.1667) 
and after (µ = 18.500) the intervention. The percentage change in the pretest/posttest 
scores were also computed using the formula [ change in % = (new mean - old mean) ÷ 
old mean × 100]. There was an average increase of 7.3 in the mean scores of the 
participants and a 65 % increase of knowledge from pretest to posttest. In order to 
evaluate if the change in the mean was statistically significant, the p-value was computed 
using the paired t test. The result (p = .022) was found to be statistically significant with α 
set at .05. Because p < α, this indicates that the intervention was successful in increasing 
providers’ confidence levels.  
After 1 month, it was noted that an increase in the difference of the mean from 7.3 
to 8.6 with a p-value of .012 indicated further improvement in the average Likert scale 
score of the participants confidence level. The education module showed significant 
improvement in the providers’ knowledge on using PHQ-9 tool for diagnosing and 
managing depression. Following the educational presentation, a hard copy of the 
educational module was presented to the clinical team (Appendix F).  
Educating providers increased their knowledge and confidence level on how to 
successfully administer PHQ-9 screening tool, which significantly increased the use of 
best practices. The primary outcome of this project was increased provider knowledge, 
confidence, and assessment skills when identifying signs and symptoms of depression in 
the clinical setting.  
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Project Implications  
This evidence-based educational program has the potential to improve knowledge 
and enhance confidence level while also integrating EBP knowledge in screening for 
depression using the PHQ-9 tool by providers by in the outpatient clinic. With all the 
positive feedback from the clinical team, along with the statistically significant results, 
this evidence-based project contributes to practice excellence and quality patient 
outcomes. According to Williams et al. (2017), depression is identified as a contributing 
factor to increased disability globally, which is costing the United states in 2016 
approximately $233 billion dollars. This educational project will positively influence 
social change by reducing the incidence of undiagnosed and untreated depression among 
patients who are seen by providers at the clinic thereby reducing the financial issues 
caused by depression on the economy (Williams, Chung, & Muennig, 2017). The 
ongoing promotion of depression screening would provide a social shift among the 
providers at the clinic by using the PHQ-9 depression screening tool to give the 
opportunity for best possible diagnosis and treatment of depression, which also will 
promote the health and wellness of clients, families, and the community. 
Recommendations 
This DNP project suggests that implementing an educational intervention on the 
use of the PHQ-9 depression screening tool is, not only beneficial to the providers, but 
also to the clinic as new hires will have the opportunity to benefit from the PowerPoint 
presentation. It should be noted that this project did not evaluate patient’s outcome as a 
result of the intervention. However, it evaluated providers’ knowledge and their 
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confidence in utilizing the PHQ-9 depression screening tool. This should assist in 
maintaining the sustainability of the use of PHQ-9 tool by providers. It is realistic to 
recommend that all new providers hired at the clinic receive this education to improve 
their knowledge and enhance their confidence level on the utilization of the PHQ-9 
depression screenings tool. Another recommendation would be incorporating a teaching 
PHQ-9 tool to new providers orientation package. This was an educational project that 
will continue to move forward long after the completion of this project and will better 
serve the needs of the patient population and the providers. 
In reviewing the responses from the questionnaire, several recommendations were 
made for future projects to address the gaps in practice. The time limitations and the 
inconsistent demands in the clinic are challenges to effectively screening patients for 
depression using PHQ-9 tool. Thus, an important recommendation was to create a 
standard documentation process for providers using the PHQ-9 tool for every patient who 
comes to the clinic. Another recommendation would be for the clinic to study patient 
outcomes as they relate to the increase usage of the PHQ-9 to determine whether 
consistent usage results in the correct diagnosis and treatment of these patients.  
This evidence-based educational program has the potential to improve knowledge 
and enhance confidence level while integrating evidence-based knowledge into practice. 
This project will influence positive social change by reducing the incidence of 
undiagnosed and untreated depressive patients who are seen at the clinic. It is 
recommended that the project be standardized for use at similar outpatient facilities 
which has many patients with the potential diagnosis of depression. The more patients are 
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diagnosed and treated for depression withing a community, the more positive outcomes 
for the patient, family, and the community. This could help reduce the financial 
constraints caused by depression on the economy (Williams, Chung, & Muennig, 2017). 
Another recommendation would be that the project be implemented over a longer period 
to verify the results of this project. Finally, looking at patient outcomes as a result of 
correctly diagnosing depression early in their treatment would be necessary to validate 
the usefulness of consistent usage of the PHQ-9. 
Contributions of the Project Team 
The Project Team 
The project team consisted of clinical team members who are experts in this field. 
The team members were very involved in the development of the project as they 
contributed in the identification of the gap in practice, reviewed and evaluated the content 
of the educational module to determine accuracy, corroborated on the instrument used for 
data collection and confirmed the pretest and posttest results. Some of the revisions made 
to the content of the educational module was based on the feedback provided by the 
clinical team also called the “Project Team”. The clinical team supported the 
development and implementation of the educational program to attain the goal of the 
project.  
The Doctor of Nursing Practice Student 
The DNP student took the leadership role in the project. The student collected the 
pre/posttest data, presented the PowerPoint educational material, and analyzed the data. 
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Both the DNP student and the project team members suggested the proposed 
recommendations. 
Strengths and Limitations of the Project 
The strength of the project is that it met the gap in practice for this outpatient 
clinic and targeted the problem the clinic was facing. Another strength was the 
collaboration the clinic gave this DNP student, as a shared goal was the overarching 
concern. The motivation of this learner to truly make a difference in the lives of patients 
suffering from depression was another strength of the project. 
Limitations included the fact that the number of participants was small so the 
result cannot be generalized. Demographically, all the participants were female, which 
could impact the way questions were answered on the pre-and-posttest surveys. All the 
participants were selected from one facility, which limits perceptual diversity in their 
responses to the questionnaire. It was difficult to have all the participants in one session 
for the PowerPoint presentation resulting in some participants reviewing the presentation 
without the opportunity to ask questions. Another limitation of this project was the 
amount of time used to collect data. The four weeks for data collection may not have 
been enough time to ensure consistency of using the PHQ-9 depression screening tool in 
managing patients with depressions. 
Summary 
This section of the project highlighted the findings and implication of the project. 
It presented the results and discussed the limitations and recommendations of the project. 
The role of the project team was also reviewed. Section Five will focus on plans for 
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disseminating the findings and recommendation to the facility and a wider audience in 
nursing. The analysis of self and the role as a practitioner, project manager, scholar will 
also be discussed including challenges and insight gained during this project.  
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Section 5: Dissemination Plan  
Dissemination 
Dissemination is an important part of any DNP project because it ensures the 
research has a social, political, or economical influence on people. Dissemination brings 
to the attention of stakeholders of research’s outcomes and conclusions, which enhances 
knowledge regarding the implementation of the research (Marín-González, Malmusi, 
Camprubí, & Borrell, 2017). The plan is to educate providers on the use of PHQ-9 
screening in outpatient clinics within my geographical area in the promotion of better 
patient outcomes for depressed patients. I also intend to present my project at a nursing 
conference and may consider publishing my project findings.  
Analysis of Self 
This DNP project helped developed my self-confidence in project implementation 
and evaluation. Furthermore, I found my ability to function in a leadership role in 
developing, improving, and decision-making process has grown. The project 
implementation improved my collaborative skills in working with the clinical team, as we 
sought to integrate evidence-based changes in an evolving healthcare system. Upon 
completion of this scholarly journey, I was able to gain confidence in speaking in public 
to an audience of peers. I learned to trust myself as a scholar and leader who has a 
knowledge set that I could share with other professionals. One of my long-term goals is 
to work in a nongovernmental organization located in a rural area where the 




The number of patients diagnosed with depression increases by about 20% each 
year. Depression often goes undiagnosed and without treatment. The United States 
reported there is an estimate two- thirds of undiagnosed depression cases, leading to 
untreated depression (Williams et al., 2017). If depression is left untreated, it can cause 
disabling symptoms that can negatively affect the quality of life. Recently, there has been 
an initiative in the United States to identify and treat depression (Sparer, Muennig, & 
Brown, 2016). This project addressed the lack of routine depression screening by 
providers to identify those at risk or needing treatment. The results from this DNP project 
support education on the use of the PHQ-9 depression screening tool to enhance 
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Note. From “Introducing Evidence into Nursing Practice: Using the Iowa Model,” by C. 













                                                                                                              FOR OFFICE CODING     0      + ______ + ______ + ______  
 
=Total Score:  ______ 
 
If you checked off any problems, how difficult have these problems made it for you to do your work, 
take care of things at home, or get along with other people?  
Not difficult at 
all  
  
Somewhat difficult  
  








   Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from 
Pfizer Inc.  No permission required to reproduce, translate, display or distribute. 
PATIENT HEALTH QUESTIONNAIRE-9   
(PHQ-9)  
Over the last 2 weeks, how often have you been 
bothered by any of the following problems? (Use “✔” to 









1. Little interest or pleasure in doing things  0  1  2  3  
2. Feeling down, depressed, or hopeless  0  1  2  3  
3. Trouble falling or staying asleep, or sleeping too much  0  1  2  3  
4. Feeling tired or having little energy  0  1  2  3  
5. Poor appetite or overeating  0  1  2  3  
6. Feeling bad about yourself — or that you are a failure or 
have let yourself or your family down  
0  1  2  3  
7. Trouble concentrating on things, such as reading the 
newspaper or watching television  
0  1  2  3  
8. Moving or speaking so slowly that other people could 
have noticed?  Or the opposite — being so fidgety or 
restless that you have been moving around a lot more than 
usual  
0  1  2  3  
9. Thoughts that you would be better off dead or of hurting 
yourself in some way  
0  1  2  3  
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Appendix C: Depression Toolkit Contents Guidelines for using PHQ-9 
PHQ-9 Depression Severity Score Proposed Treatment Actions 
0 – 4 Minimal 
No treatment recommended.  
5 – 9 Mild depression  
Watch the patient closely just in case it progresses. No treatment recommended  
10 – 14 Moderate depression  
Propose treatment and counseling.  
15 – 19 Moderately severe depression  
Patient needs active treatment: pharmacotherapy and psychotherapy.  
20 – 27 Severe depression  





Note. From “Attitudes Toward Dissertation Editors,” by W. Student, 2008, Journal of 
Academic Optimism, 98, p. 11. Reprinted with permission. [if needed?] from New York 
State Department of Health (2016). 
60 
 
Appendix D: Knowledge/Confidence Level Pre-/Posttest Questionnaire 
 
The purpose of this questionnaire is to assess provider’s knowledge/confidence level in 
the utilization of the PHQ-9 screen tool for Depression management. Please respond to 
questions 1-10 with the most appropriate answer 
1.Please indicate your age. 20-29 [], 30-39 [], 40-49 [], 50-59 [], over 60 [] 
2.What is your gender? Female [], Male [] 
3.What educational degree do you hold; NP □, MD □, PMHNP □, FNP □ 
In items 4 - 13 below, please respond with your appropriate level of agreement:  












4. I have adequate knowledge in using the PHQ -9 for 
depression screening 
     
5. I have adequate knowledge in using the PHQ -9 for 
depression diagnosis 
     
6. I have adequate knowledge in using the PHQ-9 for 
monitoring depression management 
     
7. I have adequate knowledge in using the PHQ -9 tool for 
measuring severity of depression 
     
8. I have the desire to receive further education that will 
improve my knowledge in utilizing the PHQ-9 tool  
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9. I am confident in my ability to use the PHQ-9 tool for 
depression screening 
     
10.I am confident in my ability to use the PHQ-9 tool for 
diagnosing depression  
     
11.I am confident in my ability to use the PHQ-9 tool for 
monitoring the progression of depression management 
     
12.I am confident in my ability to use the PHQ-9 tool for 
measuring the severity of depression s 
     
13.I have the desire to receive further education that will 
improve my knowledge in utilizing the PHQ-9 tool  
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